Resources and Information

»Pharmacology Update

Nov 18 2022

Floater Intervention Study

Janet Swartz, EdD

At a recent NGS webinar, there was a brief discussion of the Floater Intervention Study, which investigated the effectiveness of nutritional supplements on vitreous floaters.
read more

discuss

 

»Glaucoma Watch

Nov 14 2022

Treatment Goals in Glaucoma

Janet Swartz, EdD

Dr. Eric Schmidt discusses initial medical management of open-angle glaucoma as well as guidelines for selecting IOP targets.
read more: Full Members Only

 

»Case of the Month

Oct 20 2022

Angle Closure Glaucoma and Topomax

Bud O'Leary, OD

Dr. Nora Lee Cothran discusses a 34-year-old patient with a headache referred by the emergency room for high IOP.
read more: Full Members Only

 

»Webinars

Sep 07 2022

Instructions for NGS Webinars on WebEx

Janet Swartz, EdD

The NGS uses WebEx for its interactive webinars. Get detailed instructions including computer screen shots about joining a webinar via a link or through an Internet browser on a computer.
read more

discuss

 

»Glaucoma Watch

Sep 06 2022

Congratulations to Dr. Thimons

Janet Swartz, EdD

The National Glaucoma Society is please to announce that Dr. Jim Thimons, Chairman of the National Glaucoma Society, has been included on Newsweek's America's Best Eye Doctors 2022 list.
read more

discuss

 

»Case of the Month

Aug 31 2022

SLT as First-Line Therapy

Bud O'Leary, OD

Dr. Nate Lighthizer presents a newly diagnosed glaucoma patient and discusses the research and clinical support for SLT as first-line therapy.
read more: Full Members Only

 

»Case of the Month

Jul 21 2022

Normal Tension Glaucoma Patient

Bud O'Leary, OD

Dr. Justin Schweitzer discusses the clinical presentation and treatment plan for a 65-year-old patient with normal tension glaucoma.
read more: Full Members Only

 

»Case of the Month

Jun 13 2022

Secondary Glaucoma from Ocular Trauma

Bud O'Leary, OD

Dr. Elizabeth Muckley discusses the diagnosis and management of an African-American college athlete with hyphema and secondary glaucoma from ocular trauma, the risk of angle recession glaucoma, and the potential role of sickle cell in treatment options.
read more: Full Members Only

 

 

previous